Article Text
Summary
Seizures constitute a determining aspect in quality of life and are frequently challenging in palliative care—a field where treatment has yet to be standardised. Levetiracetam—a new generation anticonvulsant—has proved efficacy both through oral, as well as intravenous administration in the general population. This case reports on the use of continuous subcutaneous levetiracetam to effectively control seizures in a terminally ill patient without patent oral route.
- palliative care
- epilepsy and seizures
- safety
Statistics from Altmetric.com
Footnotes
Contributors IF, JG and FG were responsible for the conception and design of the work, as well as data collection, analysis and interpretation. IF drafted the the article. IF, JG, FG and JN participated in the critical revision of the article and final approval of the version to be published.
Competing interests None declared.
Patient consent Obtained.
Provenance and peer review Not commissioned; externally peer reviewed.